Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry

Published:2024-05-13 Issue: Volume: Page:1-9
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides & Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides & Nucleic Acids

Author:

Urbanowicz Krzysztof¹^ORCID,Opielka Mikolaj¹^ORCID,Stegmann Kim M.²^ORCID,Dickmanns Antje²^ORCID,Dobbelstein Matthias²^ORCID,Peters Godefridus J.¹³^ORCID,Smoleński Ryszard T.¹^ORCID

Affiliation:

1. Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland

2. Department of Molecular Oncology, Göttingen Center of Molecular Biosciences, University of Göttingen, Göttingen, Germany

3. Laboratory of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Unversteit Amsterdam, Amsterdam, the Netherlands

Funder

VolkswagenStiftung

COVID-19 Forschungsnetzwerk Niedersachsen

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2024.2346550

Reference24 articles.

1. RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

2. Paxlovid: Mechanism of Action, Synthesis, and In Silico Study

3. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

4. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

5. Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP